In the past the R & D line of least resistance is towards the development of the drug track road, now with the gradual depletion of those compounds, pharmaceutical companies are more challenging to the development of the drug. In view of the cytotoxic drug, prostaglandin, anesthetics, cancer drugs, such as strong demand for high-performance drugs, is pushing for the efficient production facilities, in order to adapt to this situation, the organization is expanding its contract production of the materials used in clinical trials and commercialization aspects of the production Capacity.
...
...